Granules receives USFDA EIR for Chantilly plant
Granules receives USFDA EIR for Chantilly plant — Granules India has received an Establishment Inspection Report (EIR) from the USFDA for its Chantilly, Virginia facility following a routine inspection. The EIR indicates no critical observations, a positive regulatory signal. This outcome supports future product approvals and export potential.
📊 STOCKS: GRANULES | 🏢 SECTOR: Pharma | #MEDIUMIMPACT #USFDA
This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.